Ishikawa S, Linzmayer I, Segal M S
Ann Allergy. 1977 Nov;39(5):303-5.
Ten patients 55 years and older, known to have chronic obstructive airway disease with reversible component and who had required daily sympathomimetics for many years, were studied. At a clinically stable state in a sitting position, spirometry, ventilation, gas exchange, diffusion and arterial blood gas determinations were performed before and 10, 30, 60 and 120 minutes after administration of 0.5 mg of terbutaline sulfate by inhalation. Although changes were small, significant improvement in FEV1 remained even two hours after inhaling terbutaline. Increase of conducting airways reflected an increase of dead space for 120 minutes. Early rise of alveolar-arterial oxygen tension (PAO2-PaO2) with decreased arterial oxygen tension was observed. This was a transient phenomenon and not severe enough to warrant immediate therapy. No significant EKG or blood pressure changes were noted throughout the study. It appears that terbutaline, an effective long acting bronchodilator, can be safely administered to older patients with bronchospasms.
对10名55岁及以上、已知患有伴有可逆成分的慢性阻塞性气道疾病且多年来每日都需要使用拟交感神经药的患者进行了研究。在临床稳定状态下,患者坐姿时,在吸入0.5毫克硫酸特布他林之前以及之后10、30、60和120分钟进行肺活量测定、通气、气体交换、弥散和动脉血气测定。尽管变化很小,但吸入特布他林后两小时FEV1仍有显著改善。传导气道增加反映了120分钟内无效腔增加。观察到肺泡-动脉氧分压(PAO2-PaO2)早期升高且动脉氧分压降低。这是一种短暂现象,严重程度不足以需要立即治疗。在整个研究过程中未观察到明显的心电图或血压变化。看来,特布他林作为一种有效的长效支气管扩张剂,可以安全地用于患有支气管痉挛的老年患者。